Cite
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.
MLA
Ndhlovu, Lishomwa C., et al. “IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (T(H)17) Cells in the Periphery.” Journal of Clinical Immunology, vol. 30, no. 5, Sept. 2010, pp. 681–92. EBSCOhost, https://doi.org/10.1007/s10875-010-9432-3.
APA
Ndhlovu, L. C., Sinclair, E., Epling, L., Tan, Q. X., Ho, T., Jha, A. R., Eccles-James, I., Tincati, C., Levy, J. A., Nixon, D. F., Hecht, F. M., & Barbour, J. D. (2010). IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. Journal of Clinical Immunology, 30(5), 681–692. https://doi.org/10.1007/s10875-010-9432-3
Chicago
Ndhlovu, Lishomwa C, Elizabeth Sinclair, Lorrie Epling, Qi Xuan Tan, Terence Ho, Aashish R Jha, Ijeoma Eccles-James, et al. 2010. “IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (T(H)17) Cells in the Periphery.” Journal of Clinical Immunology 30 (5): 681–92. doi:10.1007/s10875-010-9432-3.